Elyan Partners-advised ERES IV takes majority stake in Oncodesign Services

Oncodesign Services is a contract research organisation that specialises in drug discovery and preclinical services in oncology.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this